FIELD: medicine. SUBSTANCE: the method deals with treating inflammatory intestinal diseases, such as Crohn's disease or unspecific ulcerous colitis. Moreover, such an agent includes that interleukin-6 (IL-6) antagonist as an antibody against IL-6 receptor as an active ingredient. Thus, new method is elaborated to treat the above- mentioned diseases dealing with inhibition of cytokines' activity. EFFECT: higher efficiency of therapy. 22 cl, 4 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PROPHYLACTIC DRUG FOR VASCULITIS | 2004 |
|
RU2379054C2 |
| THERAPEUTIC AGENT FOR MESOTHELIOMA | 2004 |
|
RU2554942C2 |
| THERAPEUTIC AGENT FOR MESOTHELIOMA | 2004 |
|
RU2392967C2 |
| DRUGS AGAINST CHRONIC RHEUMATIC ARTHRITIS CONTAINING ANTAGONIST OF IL-6 AS EFFECTIVE COMPONENT | 1995 |
|
RU2147443C1 |
| PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS OR TREATMENT OF DISEASES CAUSED BY IL-6 FORMATION | 1995 |
|
RU2147442C1 |
| METHOD OF TREATING INTERLEUKIN-6-DEPENDENT DISEASES | 2004 |
|
RU2509574C2 |
| THERAPEUTIC AGENT IN SPINAL MARROW INJURY CONTAINING INTERLEUKINE-6 ANTAGONIST | 2004 |
|
RU2358761C2 |
| THERAPEUTIC AGENT FOR DISEASES, RELATED TO CHILDREN'S CHRONIC ARTHRITIC DISEASES | 2002 |
|
RU2361613C2 |
| THERAPEUTIC AGENT FOR TREATING DISEASES RELATED TO JUVENILE CHRONIC ARTHRITIS | 2002 |
|
RU2541165C2 |
| AGENT FOR CARDIOPATHY | 2006 |
|
RU2450830C2 |
